In the second quarter of this year, V Square Quantitative Management LLC made a significant reduction in its holdings of The Cigna Group (NYSE:CI). According to its most recent disclosure with the Securities & Exchange Commission, the institutional investor sold 563 shares, resulting in a decrease of 23.3% in its overall holdings. As per the filing, V Square Quantitative Management LLC now owns 1,852 shares of the health services provider’s stock. Based on the recent SEC filing, these holdings are estimated to be worth $520,000.
It is noteworthy that The Cigna Group recently announced a quarterly dividend payment. On Thursday, September 21st, investors who were recorded as shareholders on Wednesday, September 6th received a dividend of $1.23 per share. The ex-dividend date for this particular payment was Tuesday, September 5th. With an annualized dividend of $4.92 and a current dividend yield of 1.71%, this marks another opportunity for investors to benefit from The Cigna Group’s payout ratio which stands at 22.40%.
V Square Quantitative Management LLC’s decision to trim its holdings in The Cigna Group may have various implications for both parties involved. While it is crucial to note that portfolio adjustments made by institutional investors like V Square Quantitative Management LLC can be influenced by a multitude of factors outside the scope of public disclosure, such moves might reflect changes in their assessment of the company’s future prospects.
As always, potential investors should conduct thorough research and analysis before making any investment decisions based solely on news or recent developments affecting a particular stock or company. It is important to consider various factors including financial statements, market trends, and other relevant information that could impact investment outcomes.
In summary, V Square Quantitative Management LLC has reduced its stake in The Cigna Group during the second quarter of this year. The disclosure that states the sale of 563 shares, equivalent to a 23.3% decrease in holdings, shows that V Square Quantitative Management LLC now owns 1,852 shares worth $520,000. This development, combined with The Cigna Group’s recent dividend announcement, provides potential investors with additional information to consider while evaluating investment opportunities in this health services provider.
Significant Changes to Stakes in The Cigna Group by Institutional Investors and Hedge Funds
Institutional investors and hedge funds have made significant changes to their stakes in The Cigna Group, a prominent health services provider. Bank Julius Baer & Co. Ltd Zurich dramatically increased its holdings by an astounding 63,861.5% during the second quarter. This resulted in the bank owning a staggering 39,406,651 shares of The Cigna Group’s stock, valued at $11,057,506,000 after acquiring an additional 39,345,041 shares.
Another notable investor, Moneta Group Investment Advisors LLC, also experienced a remarkable increase in holdings by 154,255.6% during the fourth quarter. They now possess 11,954,841 shares valued at $3,961,117,000 after acquiring an additional 11,947,096 shares.
Similarly, Ameriprise Financial Inc. raised its stake by 22.7% in the first quarter and now owns 4,346,293 shares worth $1,$1 billion after acquiring an additional 804.805 shares.
Bank of New York Mellon Corp boosted its holdings as well by 9.5% during the third quarter and currently holds 3,,1081664 shares worth $862’423O00 after adding another
Lastly., Norpes Bangk qeiuired the stock in Seeondquarter which is approuimatelv&a-&Sjz&i .of-thest
Overall74&32% of The Cyqna Group?s Stock iisnow owned-bi-rmstitut-ionaFigvestors”andlêídge unds Tzesearch fimrs have recently-provided insight intoThe Cignactçup Regarding this matter[?JPMorgan Chase & Co.adjusted their price target from S35óo?to ÿ341`OOn Julyvthey articulateëd that ‘Bank of America raised its target from $320MO to $350:OP with a “buy” rating on August 4th. Inanother-analyticai assessment, CantorFitzgerald positiongraded&#?